Is Companion Diagnostics a Cost-Effective Option In Cancer Treatments?
The cost of a companion diagnostic can vary widely depending on several factors, such as the type of test, the complexity of the technology, the intended use, and the regulatory requirements of the country in which the test is marketed. It is important to note that the cost of a companion diagnostic is often only one aspect of the overall cost of targeted therapy.
Bio-print Model for Improved Anticancer Drugs and Treatments
Researchers create the first 3D in vitro model capable of isolating specific metastatic cells, which is useful for providing innovative treatment for cancer.
Researchers create the first 3D in vitro model capable of isolating specific metastatic cells, which is useful for providing innovative treatment for cancer.
‘The pricing of companion diagnostics in cancer care will drop soon through various initiatives by manufacturers.’
Tweet it Now
Companion diagnostics are designed to identify patients who are most likely to benefit from a particular medication or therapy, and the cost of the therapy itself can be much higher than the cost of the diagnostic test.It is important to consider the overall value of the companion diagnostic test in the context of the potential benefits of targeted therapies for patients. Most of the companion diagnostics in oncology are cost-effective.
In some cases, companion diagnostics may not be available at all in certain regions, making it difficult or impossible for patients to access the therapies they need. In other cases, companion diagnostics may be available but at a significantly higher cost, making them unaffordable for many patients.
Essential Drugs List Gets Updated With New Diabetes and Anti-Cancer Drugs
How many drugs have been listed in the National List of Essential Medicines 2022? 34 new medicines including some anticancer, and diabetic drugs, and dropped 26 old ones.
How many drugs have been listed in the National List of Essential Medicines 2022? 34 new medicines including some anticancer, and diabetic drugs, and dropped 26 old ones.
Efforts are being made to improve access to affordable companion diagnostics, particularly in developing countries, to ensure that patients can receive the most appropriate treatments for their medical conditions.
Advertisement
Cancer Drugs in Development can also Fight Certain Brain Diseases
Brain diseases like Amyotrophic Lateral Sclerosis or ALS may have found a cure with a particular class of cancer drugs called PARP inhibitors, says a new study.
Brain diseases like Amyotrophic Lateral Sclerosis or ALS may have found a cure with a particular class of cancer drugs called PARP inhibitors, says a new study.
Advertisement
Basis for New Anti-Cancer Drugs Found in Fruits and Vegetables
Nine dietary scaffolds found in non-starchy plants like broccoli, cabbage, spinach, kale, cauliflower, carrots, lettuce, cucumber, tomato, leek, rutabaga, and turnip, have shown potent anticancer properties by exhibiting inhibitory effects on different cancers.
Nine dietary scaffolds found in non-starchy plants like broccoli, cabbage, spinach, kale, cauliflower, carrots, lettuce, cucumber, tomato, leek, rutabaga, and turnip, have shown potent anticancer properties by exhibiting inhibitory effects on different cancers.
